Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of TH-SC01 for complex anal fistula
CTR20222472Phase 2Active
- Sponsor
- T-Hone Biotech
- Start
- Dec 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of TH-SC01 in complex anal fistula, sponsored by T-Hone Biotech. Started Dec 2022; status: active.
02
Drugs
TH-SC01
03
Conditions
complex anal fistula
Beyond the preview
Go deeper on CTR20222472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222472.